GARRICK HAYMORE: Open Payments
NPI 1972978328 · SIERRA VISTA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 27 payments from 15 companies in 2025. Trend: 2023 $142 · 2024 $355 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $113 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Amgen Inc. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, XIFAXAN, EVENITY, Kerendia, Belbuca, GEMTESA, GVOKE HYPOPEN.
Industry payments across AZ — which companies pay providers there.
